Drive Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Drive Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$206K	Buy	+11,146	New	+$196K	0.04%	349

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Drive Wealth Management's TAK Position: Q1 2026 in Review

Drive Wealth Management opened a new position in Takeda Pharmaceutical (TAK) in Q1 2026: 11,146 shares worth $206K. The stake represents 0.04% of the portfolio and ranks #349 among its holdings.

358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Drive Wealth Management held 11,146 shares of Takeda Pharmaceutical worth $206K as of Q1 2026.
Takeda Pharmaceutical was a new Drive Wealth Management position in Q1 2026.
Takeda Pharmaceutical made up 0.04% of Drive Wealth Management's portfolio in Q1 2026, its #349 holding.
358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Drive Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.